Ibrutinib: the first Bruton's tyrosine kinase inhibitor.
- Published in:
- Prescriber, 2018, v. 29, n. 7, p. 36, doi. 10.1002/psb.1691
- By:
- Publication type:
- Article
Works matching IS 09596682 AND DT 2018 AND VI 29 AND IP 7
Results: 8
1
2
Tackling the problem of falsified medicines in the UK.
- Published in:
- Prescriber, 2018, v. 29, n. 7, p. 33, doi. 10.1002/psb.1690
- By:
- Publication type:
- Article
3
Early diagnosis and management of systemic sclerosis.
- Published in:
- Prescriber, 2018, v. 29, n. 7, p. 27, doi. 10.1002/psb.1689
- By:
- Publication type:
- Article
4
Is the UK shingles vaccination programme fit for the future?
- Published in:
- Prescriber, 2018, v. 29, n. 7, p. 23, doi. 10.1002/psb.1688
- By:
- Publication type:
- Article
5
Assessment and management of heavy menstrual bleeding.
- Published in:
- Prescriber, 2018, v. 29, n. 7, p. 21, doi. 10.1002/psb.1687
- By:
- Publication type:
- Article
6
Prevention and treatment of venous thromboembolic disease.
- Published in:
- Prescriber, 2018, v. 29, n. 7, p. 15, doi. 10.1002/psb.1686
- By:
- Publication type:
- Article
7
What does the future hold for life sciences in the UK?
- Published in:
- Prescriber, 2018, v. 29, n. 7, p. 10, doi. 10.1002/psb.1685
- By:
- Publication type:
- Article
8
Happy birthday NHS!
- Published in:
- Prescriber, 2018, v. 29, n. 7, p. 4, doi. 10.1002/psb.1684
- By:
- Publication type:
- Article